Stock Events

Stock Events

Xeris Biopharma (2B30.F) Q3 2024 Earnings

Aug 8Confirmed

Q4 2023

Q2 2024

Q3 2024

-0.13

-0.11

-0.1

-0.08

Details

Expected EPS

-0.08883739783

Actual EPS

-0.091601

Surprise EPS

-0

Surprise Percent

-3.11%

Description

⁨Xeris Biopharma⁩ (⁦2B30.F⁩) has reported earnings of ⁦-0.091601⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.